Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
XXII 
22nd Century Group Inc (XXII)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/07/2025: XXII (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -73.78% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/07/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.49M USD | Price to earnings Ratio - | 1Y Target Price 720 |
Price to earnings Ratio - | 1Y Target Price 720 | ||
Volume (30-day avg) 75430 | Beta 2.03 | 52 Weeks Range 0.97 - 265.95 | Updated Date 04/6/2025 |
52 Weeks Range 0.97 - 265.95 | Updated Date 04/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -176.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-26 | When Before Market | Estimate - | Actual -17.8318 |
Profitability
Profit Margin -62.19% | Operating Margin (TTM) -99% |
Management Effectiveness
Return on Assets (TTM) -35.13% | Return on Equity (TTM) -385.89% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 6659334 | Price to Sales(TTM) 0.11 |
Enterprise Value 6659334 | Price to Sales(TTM) 0.11 | ||
Enterprise Value to Revenue 0.56 | Enterprise Value to EBITDA -0.47 | Shares Outstanding 2369550 | Shares Floating 2207404 |
Shares Outstanding 2369550 | Shares Floating 2207404 | ||
Percent Insiders 9.59 | Percent Institutions 2.4 |
Analyst Ratings
Rating 3 | Target Price 32.44 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
22nd Century Group Inc
Company Overview
History and Background
22nd Century Group, Inc. was founded in 1998. It is a plant biotechnology company focused on tobacco harm reduction and improving health and wellness through plant science. It has evolved from initially focusing on very low nicotine (VLN) tobacco to broader plant-based applications.
Core Business Areas
- Tobacco: Development and commercialization of VLN cigarettes aimed at reducing nicotine consumption and smoking rates.
- Hemp/Cannabis: Focuses on plant research for medical, pharmaceutical and agricultural application.
- Contract Manufacturing: Providing contract manufacturing services to supplement the tobacco and hemp businesses.
Leadership and Structure
James Mish is the current CEO. The company has a board of directors and operates with functional departments overseeing research, manufacturing, and commercialization.
Top Products and Market Share
Key Offerings
- VLN Cigarettes: Very Low Nicotine (VLN) cigarettes branded as 'VLN' are their flagship product. Market share is growing but still small. Competitors include major tobacco companies like Philip Morris International (PM), British American Tobacco (BTI), and Altria (MO).
- Hemp Genetics: Development of hemp varieties, focusing on improved yields and cannabinoid profiles. The market is nascent and rapidly evolving. Competitors include companies like Arcadia Biosciences (RKDA).
Market Dynamics
Industry Overview
The tobacco industry faces declining cigarette sales due to health concerns and regulations. The cannabis/hemp industry is growing rapidly but remains subject to regulatory uncertainty. The tobacco industry is valued at over $800 Billion in 2024, the cannabis industry TAM is estimated at $50 billion and set to grow.
Positioning
22nd Century Group is positioned as an innovator in tobacco harm reduction and plant science. Their competitive advantage lies in their patented technology for VLN tobacco and hemp. Their share of the total TAM is still small, but growing
Total Addressable Market (TAM)
The estimated TAM for the tobacco industry is approximately $800 billion worldwide. For the cannabis and hemp industry the TAM is expected to reach $50 billion by 2024. 22nd Century Group is positioned to capture a portion of the harm reduction and specialty crop markets.
Upturn SWOT Analysis
Strengths
- Patented VLN technology
- First FDA authorized reduced nicotine cigarettes
- Growing hemp/cannabis research program
- Contract Manufacturing capabilities
Weaknesses
- Limited market share
- Reliance on regulatory approvals
- History of losses
- Small size compared to major tobacco companies
Opportunities
- Increased consumer demand for reduced nicotine products
- Expansion of hemp/cannabis markets
- Partnerships with major tobacco companies
- International expansion
Threats
- Regulatory changes impacting tobacco or hemp
- Competition from established tobacco companies
- Consumer acceptance of VLN cigarettes
- Fluctuations in commodity prices
Competitors and Market Share
Key Competitors
- PM
- MO
- BTI
- RKDA
Competitive Landscape
22nd Century Group has a technological advantage with VLN, but is much smaller than major tobacco players. They rely on regulatory changes and consumer acceptance to gain market share.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth is currently minimal but the company has pivoted towards significant growth with VLN tobacco and cannabis.
Future Projections: Future growth projections depend on regulatory approvals, market acceptance of VLN cigarettes, and success in the hemp/cannabis market.
Recent Initiatives: Recent initiatives include launching VLN cigarettes in the US, expanding hemp/cannabis research, and forming partnerships to scale manufacturing.
Summary
22nd Century Group is a small company with an innovative product in the VLN cigarette market. Its success hinges on regulatory tailwinds and consumer adoption. The company faces stiff competition from large tobacco companies and its history shows losses. It needs to establish partnerships and efficiently scale production.
Similar Companies
BTI
British American Tobacco p.l.c.
BTI
British American Tobacco p.l.c.
MO
Altria Group
MO
Altria Group
PM
Philip Morris International Inc
PM
Philip Morris International Inc
RKDA
Arcadia Biosciences Inc
RKDA
Arcadia Biosciences Inc
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor. Market share information are rough estimates due to limited public information
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About 22nd Century Group Inc
Exchange NASDAQ | Headquaters Mocksville, NC, United States | ||
IPO Launch date 2011-01-26 | President, CEO & Chairman Mr. Lawrence D. Firestone | ||
Sector Consumer Defensive | Industry Tobacco | Full time employees 56 | Website https://www.xxiicentury.com |
Full time employees 56 | Website https://www.xxiicentury.com | ||
22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.